In vitro hemostatic properties of french lyophilized plasma

Anesthesiology

Volumn 117, Issue 2, 2012, Pages 339-346

  Martinaud, Christophe ^a   Civadier, Corinne ^b   Ausset, Sylvain ^c   Verret, Catherine ^d   Deshayes, Anne Virginie ^b   Sailliol, Anne ^b  

^a Fédération de Biologie Clinique   (France)

^b Centre de Transfusion Sanguine des Armees   (France)

^c Département d'Anesthésie et de Réanimation   (France)

^d Centre d'Epidémiologie et de Santé   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING INHIBITOR; FRENCH LYOPHILIZED PLASMA; FRESH FROZEN PLASMA; PLASMA SUBSTITUTE; PROTHROMBIN; RINGER LACTATE SOLUTION; THROMBIN ANTITHROMBIN COMPLEX; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING; FEMALE; FREEZE DRYING; HEMODILUTION; HEMORRHAGIC SHOCK; HEMOSTASIS; HUMAN; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; THROMBIN TIME; THROMBOELASTOGRAPHY;

BLOOD COAGULATION; BLOOD COAGULATION TESTS; FACTOR V; FACTOR VIII; FEMALE; FRANCE; FREEZE DRYING; HUMANS; MALE; PEPTIDE FRAGMENTS; PLASMA; PROTHROMBIN; THROMBELASTOGRAPHY; THROMBIN; THROMBOPLASTIN;

EID: 84864290406     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3182608cdd     Document Type: Article

References (41)

1. Bolliger D, Görlinger K, Tanaka KA: Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology 2010; 113:1205-19.
2. Ley EJ, Clond MA, Srour MK, Barnajian M, Mirocha J, Margulies DR, Salim A: Emergency department crystalloid resuscitation of 1.5 L or more is associated with increased mortality in elderly and nonelderly trauma patients. J Trauma 2011; 70:398-400.
3. Midwinter MJ, Woolley T: Resuscitation and coagulation in the severely injured trauma patient. Philos Trans R Soc Lond B Biol Sci 2011; 366:192-203.
4. Spinella PC, Holcomb JB: Resuscitation and transfusion principles for traumatic hemorrhagic shock. Blood Rev 2009; 23:231-40.
5. Gonzalez EA, Moore FA, Holcomb JB, Miller CC, Kozar RA, Todd SR, Cocanour CS, Balldin BC, McKinley BA: Fresh frozen plasma should be given earlier to patients requiring massive transfusion. J Trauma 2007; 62:112-9.
6. Zink KA, Sambasivan CN, Holcomb JB, Chisholm G, Schreiber MA: A high ratio of plasma and platelets to packed red blood cells in the first 6 hours of massive transfusion improves outcomes in a large multicenter study. Am J Surg 2009; 197:565-70; discussion 570.
7. Johnson VV, Swiatkowski SA: Scientific aspects of supplying blood to distant military theaters. Curr Opin Hematol 2007; 14:694-9.
8. Hess JR, Brohi K, Dutton RP, Hauser CJ, Holcomb JB, Kluger Y, Mackway-Jones K, Parr MJ, Rizoli SB, Yukioka T, Hoyt DB, Bouillon B: The coagulopathy of trauma: A review of mechanisms. J Trauma 2008; 65:748-54.
9. McSwain NE, Champion HR, Fabian TC, Hoyt DB, Wade CE, Eastridge BJ, Proctor KG, Rasmussen TE, Roussel RR, Butler FK, Holcomb JB, Schreiber MA, Shackford SR, Blackbourne LH: State of the art of fluid resuscitation 2010: Prehospital and immediate transition to the hospital. J Trauma 2011; 70:S2-10.
10. Rock G: A comparison of methods of pathogen inactivation of FFP. Vox Sang 2011; 100:169-78.
11. Bolliger D, Szlam F, Levy JH, Molinaro RJ, Tanaka KA: Haemodilution-induced profibrinolytic state is mitigated by fresh-frozen plasma: Implications for early haemostatic intervention in massive haemorrhage. Br J Anaesth 2010; 104:318-25.
12. Bolliger D, Szlam F, Molinaro RJ, Rahe-Meyer N, Levy JH, Tanaka KA: Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: An in vitro model. Br J Anaesth 2009; 102:793-9.
13. Arrêté du 12 janvier 2009 relatif à la sélection des donneurs de sang. Journal Officiel de la République Française 2009; 15:1067.
14. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, Lecompte T, Béguin S: Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33:4-15.
15. Pelzer H, Schwarz A, Heimburger N: Determination of human thrombin-antithrombin III complex in plasma with an enzymelinked immunosorbent assay. Thromb Haemost 1988; 59:101-6.
16. Weiss G, Lison S, Spannagl M, Heindl B: Expressiveness of global coagulation parameters in dilutional coagulopathy. Br J Anaesth 2010; 105:429-36.
17. Shuja F, Shults C, Duggan M, Tabbara M, Butt MU, Fischer TH, Schreiber MA, Tieu B, Holcomb JB, Sondeen JL: Development and testing of freeze-dried plasma for the treatment of trauma-associated coagulopathy. J Trauma 2008; 65:975-95.
18. Oktavec WA Jr, Smetana EJ: Lyophilized normal human plasma control in the prothrombin-time clotting test. Am J Clin Pathol 1954; 24:250.
19. Maurin O, Martinaud C, Boulesteix G, Eve O, Bertani A, Goudard Y, Kaiser E: Management of bleeding in a child with haemophilia in Africa with freeze-dried plasma. Haemophilia 2012; 18:e38-9.
20. Krutvacho T, Chuansumrit A, Isarangkura P, Pintadit P, Hathirat P, Chiewsilp P: Response of hemophilia A with bleeding to fresh dry plasma. Southeast Asian J Trop Med Public Health 1993; 24 Suppl 1:169-73.
21. Shuja F, Finkelstein RA, Fukudome E, Duggan M, Kheirbek T, Hamwi K, Fischer TH, Fikry K, deMoya M, Velmahos GC, Alam HB: Development and testing of low-volume hyperoncotic, hyperosmotic spray-dried plasma for the treatment of trauma-associated coagulopathy. J Trauma 2011; 70:664-71.
22. Singh Y, Sawyer LS, Pinkoski LS, Dupuis KW, Hsu JC, Lin L, Corash L: Photochemical treatment of plasma with amotosalen and longwavelength ultraviolet light inactivates pathogens while retaining coagulation function. Transfusion 2006; 46:1168-77.
23. van Rhenen D, Gulliksson H, Cazenave JP, Pamphilon D, Ljungman P, Klüter H, Vermeij H, Kappers-Klunne M, de Greef G, Laforet M, Lioure B, Davis K, Marblie S, Mayaudon V, Flament J, Conlan M, Lin L, Metzel P, Buchholz D, Corash L, euroSPRITE Trial: Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: The euroSPRITE trial. Blood 2003; 101:2426-33.
24. Jensen T, Halvorsen S, Godal HC, Skjønsberg OH: Influence of freeze-drying on the clotting properties of fibrinogen in plasma. Thromb Res 2002; 105:499-502.
25. Bakaltcheva I, O'Sullivan AM, Hmel P, Ogbu H: Freeze-dried whole plasma: Evaluating sucrose, trehalose, sorbitol, mannitol and glycine as stabilizers. Thromb Res 2007; 120:105-16.
26. Décision du 20 octobre 2010 fixant la liste et les caractéristiques des produits sanguins labiles. Journal Officiel de la République Française 2010; 276:21143.
27. Europe Committee on Blood Transfusion Guide to the preparation, use and quality assurance of blood components: Recommendation No R(95). 16th edition. Strasbourg, Council of Europe Publishing, 2010, pp 311-29.
28. von Heymann C, Keller MK, Spies C, Schuster M, Meinck K, Sander M, Wernecke KD, Kiesewetter H, Pruss A: Activity of clotting factors in fresh-frozen plasma during storage at 4 degrees C over 6 days. Transfusion 2009; 49:913-20.
29. Buchta C, Felfernig M, Höcker P, Macher M, Körmöczi GF, Quehenberger P, Heinzl H, Knöbl P: Stability of coagulation factors in thawed, solvent/detergent-treated plasma during storage at 4 degrees C for 6 days. Vox Sang 2004; 87:182-6.
30. Cardigan R, Lawrie AS, Mackie IJ, Williamson LM: The quality of fresh-frozen plasma produced from whole blood stored at 4 degrees C overnight. Transfusion 2005; 45:1342-8.
31. Heger A, Römisch J, Svae TE: Stability of solvent/detergenttreated plasma and single-donor fresh-frozen plasma during 48 h after thawing. Transfus Apher Sci 2005; 33:257-67.
32. Schoenfeld H, Pruss A, Keller M, Schuster M, Meinck K, Neuner B, von Heymann C: Lyophilised plasma: Evaluation of clotting factor activity over 6 days after reconstitution for transfusion. J Clin Pathol 2010; 63:726-30.
33. Steil L, Thiele T, Hammer E, Bux J, Kalus M, Völker U, Greinacher A: Proteomic characterization of freeze-dried human plasma: Providing treatment of bleeding disorders without the need for a cold chain. Transfusion 2008; 48:2356-63.
34. Theusinger OM, Baulig W, Seifert B, Emmert MY, Spahn DR, Asmis LM: Relative concentrations of haemostatic factors and cytokines in solvent/detergent-treated and fresh-frozen plasma. Br J Anaesth 2011; 106:505-11.
35. Theusinger OM, Baulig W, Asmis LM, Seifert B, Spahn DR: In vitro factor XIII supplementation increases clot firmness in Rotation Thromboelastometry (ROTEM). Thromb Haemost 2010; 104:385-91.
36. Mittermayr M, Streif W, Haas T, Fries D, Velik-Salchner C, Klingler A, Oswald E, Bach C, Schnapka-Koepf M, Innerhofer P: Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: The role of fibrinogen administration. Anesth Analg 2007; 105:905-17.
37. Gando S, Nanzaki S, Sasaki S, Kemmotsu O: Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation. Thromb Haemost 1998; 79:1111-5.
38. Darlington DN, Delgado AV, Kheirabadi BS, Fedyk CG, Scherer MR, Pusateri AE, Wade CE, Cap AP, Holcomb JB, Dubick MA: Effect of hemodilution on coagulation and recombinant factor VIIa efficacy in human blood in vitro. J Trauma 2011; 71:1152-63.
39. Bickell WH, Wall MJ Jr, Pepe PE, Martin RR, Ginger VF, Allen MK, Mattox KL: Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 1994; 331:1105-9.
40. Alam HB, Bice LM, Butt MU, Cho SD, Dubick MA, Duggan M, Englehart MS, Holcomb JB, Morris MS, Prince MD, Schreiber MA, Shults C, Sondeen JL, Tabbara M, Tieu BH, Underwood SA, Hemostatic Resuscitation Research Group: Testing of blood products in a polytrauma model: Results of a multi-institutional randomized preclinical trial. J Trauma 2009; 67:856-64.
41. Martinaud C, Ausset S, Deshayes AV, Cauet A, Demazeau N, Sailliol A: Use of freeze-dried plasma in French intensive care unit in Afghanistan J Trauma 2011; 71:1761-4